Supplementary Table 5 from Phase II window study of olaparib alone or with cisplatin or durvalumab in operable Head and Neck Cancer
收藏NIAID Data Ecosystem2026-05-01 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_5_from_Phase_II_window_study_of_olaparib_alone_or_with_cisplatin_or_durvalumab_in_operable_Head_and_Neck_Cancer/23696093
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table 5. Incidence of adverse events by maximum grade in the safety population.
创建时间：
2023-07-17
